ISSN: 1574-8871
Journal Home
Journal Guideline
Reviews on Recent Clinical Trials Q3 Unclaimed
Reviews on Recent Clinical Trials is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 37. It has an SJR impact factor of 0,363 and it has a best quartile of Q3. It has an SJR impact factor of 0,363.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,363
SJR Impact factor37
H Index32
Total Docs (Last Year)131
Total Docs (3 years)2429
Total Refs177
Total Cites (3 years)121
Citable Docs (3 years)1.02
Cites/Doc (2 years)75.91
Ref/DocOther journals with similar parameters
Canadian Respiratory Journal Q3
Current Stem Cell Research and Therapy Q3
Polish Journal of Microbiology Q3
JMIR Research Protocols Q3
Deutsches AÃàrzteblatt international Q3
Compare this journals
Aims and Scope
Best articles by citations
Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
View moreEffect of Flaxseed on Blood Lipid Level in Hyperlipidemic Patients
View moreNelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies
View moreMolecular Targeting in Pancreatic Cancer
View morePost Hemorrhoidectomy Pain Management: The Latest News
View moreParallel Conduction of the Phase I Preventive and Therapeutic Trials Based on the Tat Vaccine Candidate
View moreVascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials
View moreOrthotopic Liver Transplantation in Non-Alcoholic Fatty Liver Disease Patients
View moreEditorial (Thematic Issue: Non-Alcoholic Fatty Liver Disease: Today and Tomorrow)
View moreInduction of Labour for Maternal Request: An Observational Study of Maternal and Fetal Outcomes
View moreReceptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
View morePharmacokinetic Properties of Rituximab
View moreTherapeutic Strategies for Targeting BRAF in Human Cancer
View moreAdvanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Mutation: First Line Treatment and Beyond
View moreEditorial (Thematic Issue: The Long Way to a Successful Medical Therapy of Heart Failure with Beta-blockers in Children with Heart Disease)
View moreEditorial (Thematic Issue: The Urgent Need to Reform the Present System of Medicines' Regulation)
View moreCurrent Status of Clinical Trials for Glioblastoma
View moreAuthor Index To Volume 1
View morePOSTOPERATIVE COMPLICATIONS IN HEMORRHOIDAL DISEASE AND SPECIAL CONDITIONS.
View moreIs Atorvastatin Superior to Other Statins? Analysis of the Clinical Trials with Atorvastatin Having Cardiovascular Endpoints
View moreUnsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi
View moreNew Treatment Concepts In Diffuse Large B-Cell Lymphomas (DLBL): Chemotherapy and Biological Therapy
View moreClinical Development of mTOR Inhibitors: A Focus on Lymphoma
View moreThe Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
View more
Comments